I recently received an 18F-DCFPyL scan at a Stanford trial. To summarize the report, a low-dose CT was done for calibration/correction/etc, before the actual DCF scan was done (I'm assuming). This sounds like a standard piece that precedes scans like this.
The report came back with a bit of uptake in one lymph node and maybe 4 foci in seminal vesicle; no bone mets; and this:
"New PyL uptake in hepatic segment 4A/b lesion without definite CT correlate"
...with the Impression describing it as "concerning for hepatic metastasis".
Can someone offer insight in particular on the lack of a CT correlate?
-- why might this kind of thing happen?
-- does it suggest anything at all (other than need for followup, which I'm doing)?
-- is there a way these types of things typically play out ... in particular, in the liver ... e.g. is it "likely" a false positive?
-- is it just a result of low-dose CT (such that now I need the real deal CT or MRI)?
If this is typically about the low-dose calibration CT, it makes me wonder why the other foci didn't have the same thing, since they were quite small (4-7mm). Does it mean the liver spot was even smaller than that? Seems like in that case, none of what was seen here would show up on a standard CT or MRI, am I right? Likely I'm conflating some things here based on my ignorance.
Any thoughts at all to fill the vacuum are appreciated, while I wait for the next radiologist to offer an interpretation. Hopefully your thoughts will help guide my followup questions once that's done.
Thanks very much in advance.